Abstract
Pathological lymph-node status after neoadjuvant treatment and surgery (ypN) is prognostic in gastric cancer but unavailable before resection. We developed a pilot prediction model to estimate ypN risk from seven variables recorded before radical surgery in patients treated within a single-center PIPAC program; the timing of blood counts relative to neoadjuvant treatment could not be established. Of 62 patients, 47 with recorded ypN were analyzed (18 ypN-positive). Predictors were clinical T and N stage, tumor grade, age, body-mass index, white-cell count, and platelet count. Ridge logistic regression (primary), random forest, and Firth logistic regression were evaluated by cross-validation. Out-of-fold AUCs were 0.701 (95% confidence interval 0.539-0.851), 0.667 (0.488-0.831), and 0.703 (0.532-0.851), respectively; Brier scores were 0.227, 0.227, and 0.222 (prevalence-only reference 0.236). Performance was modest and imprecise; because the predictor panel was selected using the same cross-validation, estimates may be optimistic. These findings are an exploratory signal requiring independent validation.
Supplementary Files
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Original Article
ELECTRON J GEN MED, Volume 23, Issue 6, December 2026, Article No: em764
https://doi.org/10.29333/ejgm/19775
Publication date: 04 Nov 2026
Article Views: 20
Article Downloads: 9
Open Access References How to cite this article
Full Text (PDF)